duloxetine hydrochloride has been researched along with trospium chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rovner, ES; Wein, AJ | 1 |
| Hsieh, M; Kershen, RT | 1 |
| Paraiso, M; Thacker, HL | 1 |
2 review(s) available for duloxetine hydrochloride and trospium chloride
| Article | Year |
|---|---|
Update on overactive bladder: pharmacologic approaches on the horizon.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Adrenergic beta-3 Receptor Antagonists; Benzhydryl Compounds; Benzilates; Benzofurans; Botulinum Toxins; Cresols; Dosage Forms; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation; Duloxetine Hydrochloride; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Thiophenes; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders | 2003 |
Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine.
Topics: Benzilates; Benzofurans; Clinical Trials as Topic; Duloxetine Hydrochloride; Humans; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Quinuclidines; Selective Serotonin Reuptake Inhibitors; Solifenacin Succinate; Tetrahydroisoquinolines; Thiophenes; Urinary Incontinence | 2004 |
1 other study(ies) available for duloxetine hydrochloride and trospium chloride
| Article | Year |
|---|---|
Overactive bladder.
Topics: Benzilates; Duloxetine Hydrochloride; Humans; Nortropanes; Parasympatholytics; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |